Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000470192> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2000470192 endingPage "58" @default.
- W2000470192 startingPage "54" @default.
- W2000470192 abstract "A 73-year-old male patient presented with unresectable advanced esophageal cancer and metastases in the left axillary, the thoracic and the paraaortic lymph nodes, which were treated with docetaxel/nedaplatin (CDGP)/5-fluorouracil (5-FU) therapy. CDGP was administered in multiple divided doses, because the patient exhibited decreased renal function. One cycle of chemotherapy consisted of CDGP (20 mg/body/day) and 5-FU (750 mg/body/day) from days 1 to 5, docetaxel (60 mg/body) on day 1, followed by a three-week interval. The patient underwent four cycles of chemotherapy. Upper gastrointestinal endoscopy was performed after the completion of the third cycle, when the patient exhibited no evidence of a primary tumor, and no cancer cells were detected via biopsy. The efficacy of the chemotherapy was maintained after the fourth cycle, indicating a complete response(CR). Computed tomography was performed after the first cycle and showed a reduction of the primary tumor(CR) and lymph node metastases. After the fourth cycle, enlarged lymph nodes were remarkably reduced, which was assessed as a partial response(PR). The reported adverse events were Grade 1 pyrexia, Grade 3 diarrhea and Grade 2 leukopenia.Therefore, docetaxel/CDGP/5-FU therapy is a promising regimen for advanced esophageal cancer in association with a lower incidence of nephrotoxicity and hepatotoxicity." @default.
- W2000470192 created "2016-06-24" @default.
- W2000470192 creator A5001657447 @default.
- W2000470192 creator A5009766669 @default.
- W2000470192 creator A5032190268 @default.
- W2000470192 creator A5038240240 @default.
- W2000470192 creator A5038512357 @default.
- W2000470192 creator A5058095237 @default.
- W2000470192 creator A5070178577 @default.
- W2000470192 creator A5074074813 @default.
- W2000470192 creator A5080578342 @default.
- W2000470192 date "2010-01-01" @default.
- W2000470192 modified "2023-09-30" @default.
- W2000470192 title "Unresectable Advanced Esophageal Cancer Responded to Docetaxel/nedaplatin/5-fluorouracil Therapy: A Case Report" @default.
- W2000470192 cites W130289360 @default.
- W2000470192 cites W1878554291 @default.
- W2000470192 cites W2012524210 @default.
- W2000470192 cites W2031772203 @default.
- W2000470192 cites W2093658700 @default.
- W2000470192 cites W2122866527 @default.
- W2000470192 cites W2141592118 @default.
- W2000470192 cites W2313578945 @default.
- W2000470192 cites W2396407150 @default.
- W2000470192 cites W2399908457 @default.
- W2000470192 cites W2422002684 @default.
- W2000470192 cites W2428095802 @default.
- W2000470192 cites W40644723 @default.
- W2000470192 doi "https://doi.org/10.4993/acrt.18.54" @default.
- W2000470192 hasPublicationYear "2010" @default.
- W2000470192 type Work @default.
- W2000470192 sameAs 2000470192 @default.
- W2000470192 citedByCount "0" @default.
- W2000470192 crossrefType "journal-article" @default.
- W2000470192 hasAuthorship W2000470192A5001657447 @default.
- W2000470192 hasAuthorship W2000470192A5009766669 @default.
- W2000470192 hasAuthorship W2000470192A5032190268 @default.
- W2000470192 hasAuthorship W2000470192A5038240240 @default.
- W2000470192 hasAuthorship W2000470192A5038512357 @default.
- W2000470192 hasAuthorship W2000470192A5058095237 @default.
- W2000470192 hasAuthorship W2000470192A5070178577 @default.
- W2000470192 hasAuthorship W2000470192A5074074813 @default.
- W2000470192 hasAuthorship W2000470192A5080578342 @default.
- W2000470192 hasBestOaLocation W20004701921 @default.
- W2000470192 hasConcept C121608353 @default.
- W2000470192 hasConcept C126322002 @default.
- W2000470192 hasConcept C126894567 @default.
- W2000470192 hasConcept C141071460 @default.
- W2000470192 hasConcept C143998085 @default.
- W2000470192 hasConcept C2776694085 @default.
- W2000470192 hasConcept C2778203143 @default.
- W2000470192 hasConcept C2778239845 @default.
- W2000470192 hasConcept C2779742542 @default.
- W2000470192 hasConcept C2781190966 @default.
- W2000470192 hasConcept C71924100 @default.
- W2000470192 hasConcept C90924648 @default.
- W2000470192 hasConceptScore W2000470192C121608353 @default.
- W2000470192 hasConceptScore W2000470192C126322002 @default.
- W2000470192 hasConceptScore W2000470192C126894567 @default.
- W2000470192 hasConceptScore W2000470192C141071460 @default.
- W2000470192 hasConceptScore W2000470192C143998085 @default.
- W2000470192 hasConceptScore W2000470192C2776694085 @default.
- W2000470192 hasConceptScore W2000470192C2778203143 @default.
- W2000470192 hasConceptScore W2000470192C2778239845 @default.
- W2000470192 hasConceptScore W2000470192C2779742542 @default.
- W2000470192 hasConceptScore W2000470192C2781190966 @default.
- W2000470192 hasConceptScore W2000470192C71924100 @default.
- W2000470192 hasConceptScore W2000470192C90924648 @default.
- W2000470192 hasIssue "2" @default.
- W2000470192 hasLocation W20004701921 @default.
- W2000470192 hasOpenAccess W2000470192 @default.
- W2000470192 hasPrimaryLocation W20004701921 @default.
- W2000470192 hasRelatedWork W2037231595 @default.
- W2000470192 hasRelatedWork W2133454429 @default.
- W2000470192 hasRelatedWork W2219317424 @default.
- W2000470192 hasRelatedWork W2375093690 @default.
- W2000470192 hasRelatedWork W2400078616 @default.
- W2000470192 hasRelatedWork W2417237371 @default.
- W2000470192 hasRelatedWork W2472072813 @default.
- W2000470192 hasRelatedWork W2763767950 @default.
- W2000470192 hasRelatedWork W2963563988 @default.
- W2000470192 hasRelatedWork W2979342173 @default.
- W2000470192 hasVolume "18" @default.
- W2000470192 isParatext "false" @default.
- W2000470192 isRetracted "false" @default.
- W2000470192 magId "2000470192" @default.
- W2000470192 workType "article" @default.